Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
about
Epigallocatechin Gallate Nanodelivery Systems for Cancer TherapyNatural product-based nanomedicine: recent advances and issuesGreen Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.Impact of nanotechnology in cancer: emphasis on nanochemopreventionNanoformulation of natural products for prevention and therapy of prostate cancer.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.NutriTRAILomics in prostate cancer: time to have two strings to one's bow.Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer.Cancer chemoprevention by polyphenols and their potential application as nanomedicine.Delivering flavonoids into solid tumors using nanotechnologies.Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.Encapsulation of natural polyphenolic compounds; a review.Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation.Spray Dried Extract of Phormidium valderianum as a Promising Source of Natural Antioxidant.EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.Gastrointestinal interactions, absorption, splanchnic metabolism and pharmacokinetics of orally ingested phenolic compounds.Procyanidins from evening primrose (Oenothera paradoxa) defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis.Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration.Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
P2860
Q26746909-6A7FC2D7-7A40-4E76-BE01-36E380E1ED7AQ26785633-65397A5B-5B10-4FDF-865A-A6AF31B04918Q33845027-3DC2B87A-4629-444B-BF34-FAEEFD399FB6Q35750624-A34BB13E-7B1F-4A5F-B2EC-FF68F3246256Q37473193-29B36EB0-ABB9-419C-B03A-24088ADC8D15Q37646827-32B9F8E6-3083-4094-8591-9B8AEB5A2184Q37965036-84E15C35-418F-49AD-BDE2-7E5FDDB644EDQ38078272-35F14E4E-E9AA-4C34-8432-AC29210590DEQ38093653-5A8D641F-6A2D-4F95-BA62-1F88A980BF4DQ38122177-A9209C5E-FCFF-4F71-93EB-D87039A209C6Q38140631-972F25ED-DFE4-46AB-B8F6-D939032CC2D9Q38168994-A346A9EC-8AB8-434F-A9F1-4C84F6214ABCQ38217070-977BB0CF-3DC0-4CED-B70E-F039AC7E913FQ38284448-932369DF-D8E2-4EAC-BFE1-241AD06B379CQ38812845-B312850C-5139-4BA7-86E8-6284364FE69BQ38958946-67DAA742-4C60-462E-B57C-4E8A1340BEEAQ39079382-1BB92DF6-00E5-462B-8B2D-ACAA98ED276FQ39085358-431786F5-CB58-47A2-AE18-218C65186296Q39297714-06215C43-8EA6-45E2-8186-641E8D8B0646Q47561453-898E66DE-26EE-4461-8554-4DE43C4D7FA5
P2860
Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epigallocatechin gallate-loade ...... ostate cancer chemoprevention.
@en
Epigallocatechin gallate-loade ...... ostate cancer chemoprevention.
@nl
type
label
Epigallocatechin gallate-loade ...... ostate cancer chemoprevention.
@en
Epigallocatechin gallate-loade ...... ostate cancer chemoprevention.
@nl
prefLabel
Epigallocatechin gallate-loade ...... ostate cancer chemoprevention.
@en
Epigallocatechin gallate-loade ...... ostate cancer chemoprevention.
@nl
P2093
P356
P1433
P1476
Epigallocatechin gallate-loade ...... rostate cancer chemoprevention
@en
P2093
Ivone Peres
Petras Juzenas
Roman Generalov
Sandra Rocha
P356
10.2217/NNM.10.101
P577
2011-01-01T00:00:00Z